MAY 31, 2017 02:43 PM PDT

Modified Antibiotic Makes for Powerful Weapon Against Superbugs

WRITTEN BY: Carmen Leitch

Antibiotic-resistant bacteria are a major cause for concern, and these pathogens are expected to become a serious threat to humanity in the future. Developing and improving antibiotics is essential if we are to successfully face this challenge. There is some good news to report on that front; scientists have modified an existing antibiotic, vancomycin, and successfully made this life-saving drug even more potent.

"Doctors could use this modified form of vancomycin without fear of resistance emerging," explained Dale Boger, co-chair of TSRI's Department of Chemistry and leader of the work, which was published in the Proceedings of the National Academy of Sciences

Vancomycin is an effective drug that has been is use for 60 years, and makes a great starting point for the creation of improved antibiotics because it has been prescribed for so long with microbes only now beginning to build a resistance to it. Vancomycin disrupts the synthesis of cell walls in bacteria, and it seems those bugs have not been good at overcoming that mode of efficacy.

Boger thinks vancomycin is "magical" for its proven power against infections, and previous work by Boger and his team at TSRI has indicated that by making two modifications to vancomycin, it’s possible to make it even more effective. "With these modifications, you need less of the drug to have the same effect," Boger explained.

Related: Antibiotic Resistance Gene Appears on US Farm

In this new work, the investigators have shown that an additional modification can be made, one that disrupts the cell wall of bacteria in a different way. The researchers were encouraged by their findings. When used in conjunction with the previous two modifications, there is a 1,000-fold increase in the activity of vancomycin.  With a drug that powerful, far less antibiotic would be required for most patients to fight infection.

This work also makes this thrice-modified vancomycin the first antibiotic to have three different modes of action. "This increases the durability of this antibiotic," said Boger. "Organisms just can't simultaneously work to find a way around three independent mechanisms of action. Even if they found a solution to one of those, the organisms would still be killed by the other two.”

The modified drug was tested on Enterococci bacteria, it was found that the modified vancomycin was able to destroy both Enterococci as well as vancomycin-resistant Enterococci.

Next, the scientists are aiming to streamline the synthesis of the modified vancomycin so that fewer steps will be needed; it currently is a 30 step process to make it. But Boger said that will be the "easy part" of the research when compared with the challenge of engineering the molecule.

"Antibiotics are total cures for bacterial infections," said Boger. "Making this molecule is important, even by the current approach, if the failure of antibiotics continues."


Sources: Sciencedaily via TSRI, PNAS

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 25, 2018
SEP 25, 2018
Post-Hurricane Bacterial Threats
Natural disasters like hurricanes are dangerous when they occur, and their aftermath poses another set of problems....
OCT 25, 2018
OCT 25, 2018
Common Herbicides Increase Antibiotic Resistance
If we have to feed a growing planet, it may hurt us in the long run if the methods used in farming are actually increasing antibiotic-resistance in bacteria....
NOV 09, 2018
NOV 09, 2018
Lyme Disease And The Heart
In small-town New England, everyone knows the unique characteristic symptom of Lyme disease. A bulls-eye pattern rash around a tiny tick bite, infection gr...
NOV 13, 2018
NOV 13, 2018
Bacteria Offers Solution to Inflammation
A team of researchers surveys the mutualistic relationship between gut bacteria and host in regards to gut inflammation in zebrafish...
NOV 25, 2018
Drug Discovery
NOV 25, 2018
Advancing Drug Therapies for an Increasing Case of a Parasitic infection Among Displaced Syrians
Cases of Cutaneous leishmaniasis (CL), a parasitic disease, has increased dramatically in Syria and neighboring countries as a result of the conflict-relat...
DEC 06, 2018
DEC 06, 2018
A Bacterial Protein can Encourage Cancer Development
It's been suggested that a fifth of all cancers are caused by microbial infections, and new work indicates that the estimate is probably low....
Loading Comments...